Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
Tickers ASLN
Tags ASLN Trading Ideas Penny Stocks
From Benzinga
Opiant Pharma Starts Dosing In OPNT002 Mid-Stage Study For Alcohol Use Disorder
Tickers OPNT
Tags Biotech Benzinga Health Care
From Benzinga
FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
Tickers EQRX TPTX
Tags Market News why it's moving Trading Ideas
From Benzinga
FDA Gives Green Signal To Compass Therapeutics' Mid-Stage Biliary Tract Cancer Trial In US
Tickers CMPX
Tags News Health Care Penny Stocks
From Benzinga
FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors
Tickers NUVB
Tags Biotech Benzinga Briefs
From Benzinga
KemPharm To Develop KP1077 As Lead SDX Candidate For Chronic Sleep Disorder
Tickers KMPH
Tags News Earnings Health Care
From Benzinga
Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients
Tickers BGNE LPTX
Tags Briefs Benzinga LPTX
From Benzinga
Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer
Tickers CRDF
Tags News Trading Ideas Phase 1 Trial
From Benzinga
RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance
Tickers RDHL
Tags General Phase 2 Trial Briefs
From Benzinga
Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
Tickers PCVX
Tags General Small Cap Phase 2 Trial
From Benzinga
Ocugen Reveals Data From Bharat Biotech Partnered Covaxin Booster Dose
Tickers OCGN
Tags Long Ideas Briefs Biotech
From Benzinga
Exclusive: Longeveron Kickstarts Its Mid-Stage Alzheimer's Disease Trial
Tickers LGVN
Tags Health Care Alzheimer's disease Benzinga
From Benzinga
Annexon's Interim Mid-Stage Results On Huntington's Disease Candidate Fails To Cheer
Tickers ANNX
Tags Biotech Movers Benzinga
From Benzinga
Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
Tickers MREO
Tags Penny Stocks Phase 1 Trial Health Care
From Benzinga
PhaseBio Pulls Plug On Mid-Stage Hypertension Asset
Tickers PHAS
Tags General Phase 2 Trial Briefs
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Market News ADVM Penny Stocks
From Benzinga
CytomX Posts Interim Data From Phase 2 Trial Of CD71-Targeting Cancer Candidate
Tickers ABBV CTMX
Tags Market News Trading Ideas ABBV
From Benzinga
Can-Fite Shares Rally As Namodenoson Clears All Cancer Lesions In Liver Cancer Patient
Tickers CANF
Tags Phase 2 Trial hepatocellular cancer Liver Cancer
From Benzinga
Bellerophon Stock Surges After Positive Data From Sarcoidosis-Associated Pulmonary Hypertension Trial
Tickers BLPH
Tags Sarcoidosis Penny Stocks Trading Ideas
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Tickers QURE
Tags News gene therapy Trading Ideas
From Benzinga
Arcturus Shares Shoot Higher After Additional Data From COVID-19 Vaccine Programs
Tickers ARCT BNTX PFE
Tags Market News BNTX ARCT
From Benzinga
Cullinan Oncology Posts Updated Data for CLN-081 in NSCLC EGFR Exon 20 Patients
Tickers CGEM
Tags Market News News Phase 1 Trial
From Benzinga
Axcella Kickstarts Long COVID Phase 2 Clinical Trial
Tickers AXLA
Tags Briefs Movers Biotech
From Benzinga
Seres Posts Interim Microbiome Data Analysis From Failed Ulcerative Colitis Study
Tickers MCRB
Tags Market News News ulcerative colitis
From Benzinga
Vaxart to Test Cross-Reactivity of its COVID-19 Oral Vaccine Against Omicron
Tickers VXRT
Tags COVID/19 Vaccine General Small Cap
From Benzinga
GeoVax Initiates Phase 2 Trial For COVID-19 Vaccine Booster
Tickers GOVX
Tags Phase 2 Trial COVID/19 Vaccine General
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags COVID/19 Coronavirus Health Care News
From Benzinga
Final Data Reaffirms Efficacy Of Pfizer's COVID-19 Antiviral Treatment
Tickers PFE
Tags Briefs PFE Benzinga
From Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
Tickers APTO
Tags ASH21 Market News News
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
Tickers GILD
Tags Health Care News GILD
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.